Sanofi (NASDAQ:SNY) Short Interest Update

Sanofi (NASDAQ:SNY) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 5,290,000 shares, an increase of 25.7% from the December 31st total of 4,210,000 shares. Based on an average daily trading volume, of 2,420,000 shares, the days-to-cover ratio is currently 2.2 days. Approximately 0.2% of the company’s stock are sold short.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of SNY. Jennison Associates LLC boosted its stake in Sanofi by 938.0% during the 3rd quarter. Jennison Associates LLC now owns 1,904,445 shares of the company’s stock worth $109,753,000 after purchasing an additional 1,720,972 shares during the period. Thrivent Financial for Lutherans boosted its stake in Sanofi by 28,890.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 1,429,219 shares of the company’s stock worth $82,366,000 after purchasing an additional 1,424,289 shares during the period. DAVENPORT & Co LLC boosted its stake in Sanofi by 40.7% during the 4th quarter. DAVENPORT & Co LLC now owns 2,295,569 shares of the company’s stock worth $110,715,000 after purchasing an additional 664,455 shares during the period. JPMorgan Chase & Co. boosted its stake in Sanofi by 20.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock worth $133,172,000 after purchasing an additional 399,301 shares during the period. Finally, Franklin Resources Inc. boosted its stake in Sanofi by 13.1% during the 3rd quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock worth $208,106,000 after purchasing an additional 395,744 shares during the period. 14.04% of the stock is owned by hedge funds and other institutional investors.

Sanofi Stock Down 1.8 %

Shares of NASDAQ SNY traded down $0.99 during mid-day trading on Monday, reaching $53.35. The company had a trading volume of 1,890,724 shares, compared to its average volume of 2,654,421. The company has a current ratio of 1.46, a quick ratio of 0.74 and a debt-to-equity ratio of 0.15. The firm has a 50 day simple moving average of $49.24 and a two-hundred day simple moving average of $52.30. The stock has a market cap of $135.39 billion, a P/E ratio of 21.43, a PEG ratio of 1.26 and a beta of 0.57. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.58%. Sell-side analysts predict that Sanofi will post 4.34 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on SNY. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research report on Thursday. Finally, StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Sanofi currently has an average rating of “Buy” and an average target price of $60.00.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.